NVNO vs. NSPR, VANI, MBOT, UTMD, RCEL, PROF, CVRX, NPCE, DCTH, and ARAY
Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include InspireMD (NSPR), Vivani Medical (VANI), Microbot Medical (MBOT), Utah Medical Products (UTMD), AVITA Medical (RCEL), Profound Medical (PROF), CVRx (CVRX), NeuroPace (NPCE), Delcath Systems (DCTH), and Accuray (ARAY). These companies are all part of the "medical" sector.
enVVeno Medical (NASDAQ:NVNO) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, community ranking, institutional ownership, profitability and dividends.
enVVeno Medical received 154 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 62.65% of users gave enVVeno Medical an outperform vote while only 3.57% of users gave InspireMD an outperform vote.
34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 17.0% of enVVeno Medical shares are held by insiders. Comparatively, 29.7% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
InspireMD has a consensus price target of $4.85, suggesting a potential upside of 82.33%. Given InspireMD's higher probable upside, analysts clearly believe InspireMD is more favorable than enVVeno Medical.
enVVeno Medical has a net margin of 0.00% compared to InspireMD's net margin of -350.35%. InspireMD's return on equity of -55.12% beat enVVeno Medical's return on equity.
InspireMD has higher revenue and earnings than enVVeno Medical. InspireMD is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
enVVeno Medical has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.
In the previous week, enVVeno Medical and enVVeno Medical both had 1 articles in the media. enVVeno Medical's average media sentiment score of 1.63 beat InspireMD's score of 0.30 indicating that enVVeno Medical is being referred to more favorably in the media.
Summary
InspireMD beats enVVeno Medical on 9 of the 15 factors compared between the two stocks.
Get enVVeno Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
enVVeno Medical Competitors List
Related Companies and Tools
